Selective HDAC inhibition is an interesting topic in drug discovery as HDACs are implicated in the development of many types of cancer, diabetes, and inflammatory, neurodegenerative, and cardiovascular diseases, amongst others [18,21,23,24,25]. The gene discussed is HDAC9; the disease is diabetes mellitus.